Spots Global Cancer Trial Database for Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer

Official Title: ORIEN-PROGENY Family History Questionnaire Study: Recognizing Inherited Susceptibility to Cancer

Study ID: NCT03348137

Conditions

Malignant Neoplasm

Interventions

Questionnaire Administration

Study Description

Brief Summary: This research trial studies how well Oncology Research Information Exchange Network (ORIEN) works in improving genetic screening rate in patients with cancer. Implementation of Progeny Genetic Pedigree and Family History Questionnaire software across all ORIEN member institutions may add value and utility for recognizing and caring for patients with an inherited susceptibility to cancer.

Detailed Description: PRIMARY OBJECTIVES: I. Measure the change in uptake of cancer genetic referrals and genetic testing in the ORIEN system of cancer centers implementing the Progeny Family History Questionnaire (FHQ). SECONDARY OBJECTIVES: I. Follow and estimate utilization of preventive health behaviors among Progeny FHQ users across all institutions. II. Compare utilization of preventive health behavior between Progeny FHQ risk identification and genetic testing. OUTLINE: Patients take Progeny Genetic Pedigree and Family History Questionnaire. Results are reviewed by the site specific research coordinator and/or genetic counselor to assess whether a patient fulfills criteria for referral to the site specific cancer genetics clinic for further evaluation. After completion of study, patients are followed up at 6 months after disclosure of genetic testing results.